调味品行业大揭秘(共2份)
买一份就够了~
-
艾媒报告|2019中国即时配送市场研究报告
本报告研究涉及企业/品牌/案例:美团点评、UU跑腿、邻趣、快服务、闪送、阿里巴巴集团、蚂蚁金服集团、饿了么,菜鸟网络,顺丰,天猫,东方汇富、汇德丰、因诺资产、新达达,沃尔玛,京东,苏宁,点我达,盒马、银泰、屈臣氏、世纪联华、大润发、星巴克、瑞幸咖啡
即时配送服务在新零售概念的推行下迅速普及,其通过打通线上线下销售,建立短途物流体系,解决传统配送服务中同城配送的问题,已成为商业发展的必然趋势。2018年中国即时配送市场用户规模继续稳定增长。iiMedia Research(艾媒咨询)数据显示,2018年中国即时配送用户规模达到3.58亿人,预计2019年突破4亿人。新零售业务无疑是即时配送行业发展的重要增长点。在关于即时配送用户使用的服务品类调查中,下单生鲜水果、日用品、鲜花、文件资料等服务的用户占比均超过20%。而用户偏好新零售业务中,偏好下单如医药健康等其他品类即时配送服务的用户较2017年第一季度上升了106.1%。
With the spread of New Retail concept, the immediate delivery service has been rapidly popularized. As it solve the in-city delivery problem which emerge in the traditional delivery services by opening up online-offline sales and establishing the short-distance logistics system, it has become an inevitable trend of commercial development. In 2018, the scale of China Immediate Delivery users continued to grow steadily. As the data of iiMedia Research showed, the scale of the users has reached 358 million, and expected to exceed 400 million in 2019. New retail business is undoubtedly an important growth point in the development of Immediate Delivery industry. The results of the survey for services used by immediate delivery users showed that, the proportion of users who had relatively ordered fresh fruits, daily necessities, flowers, documents and etc. are all greater than 20%. As for the new retail services, users who prefer other types of immediate delivery services, such as medicine delivery, increased by 106.1% compared with the one in the first quarter of 2017. -
艾媒咨询|2020-2021中国在线直播行业年度研究报告
2020年中国直播电商市场规模达到9610亿元,同比增长121.5%。随着教育直播等细分领域快速发展,中国整体在线直播用户规模达5.87亿人。首先是国家制定政策给予支持,积极推动行业发展,为直播行业提供了良好的发展环境。同时,居民在线上消费支出的逐年上涨为直播电商提供积极的社会消费环境。直播企业的兴起也带动了相关行业发展,中国MCN机构数量迅速增长且前景持续向好。iiMedia Research(艾媒咨询)数据显示,用户对直播认可度较高。其中公益直播获65.6%的用户认可,认可度高居首位。社会公益性和非利益性是用户对直播认可度的关键,而专职带货的电商直播亦有良好的社会认可度。电商直播为用户最常观看的直播类型,约五成用户频繁观看,其中17.0%的用户观看频率非常频繁。未来在线直播平台将提高多元实时交互功能,互联网用户的参与度以及直播的关注度将进一步提升。
In 2020, China's live broadcast e-commerce market will reach 961 billion yuan, a year-on-year increase of 121.5%. With the rapid development of education live broadcast and other sub-fields, the overall online live broadcast user scale in China has reached 587 million. The first is that the country formulates policies to support it, actively promotes the development of the industry, and provides a good development environment for the live broadcast industry. At the same time, residents' online consumption expenditure has been rising year by year to provide a positive social consumption environment for live broadcast e-commerce. The rise of live broadcasting companies has also led to the development of related industries. The number of MCN organizations in China has grown rapidly and the prospects continue to improve. According to data from iiMedia Research, users have a high degree of recognition for live broadcasting. Among them, public welfare live broadcasting has been recognized by 65.6% of users, and the recognition ranks first. Social welfare and non-profit is the key to users' recognition of live broadcasts, and full-time e-commerce live broadcasts with goods also have good social recognition. E-commerce live broadcast is the most frequently watched type of live broadcast by users. About 50% of users watch it frequently, and 17.0% of users watch it frequently. In the future, online live broadcast platforms will improve multiple real-time interactive functions, and the participation of Internet users and the attention of live broadcasts will further increase. -
艾媒报告|2020H1后疫时代全球呼吸机等医疗器械产品监测及企业案例报告
本报告研究涉及企业/品牌/案例:美敦力,GE医疗,迈瑞医疗,万孚生物,鱼跃医疗,乐普医疗,九安医疗;其他提及企业/品牌:冠昊生物,华海药业,金域医学,卫宁健康,新和成,健帆生物,费森尤斯医疗,嘉德诺,丹纳赫,史赛克,依视路陆逊梯卡,创业慧康,康恩贝,华北制药,通用电气,西门子,飞利浦,3M,绿盾,霍尼韦尔,保为康POWECOM,CM朝美,UVEX优唯斯,南丁,云南白药,维康WECAN,振德医疗,迪卡侬,锐步,速尔,爱康,KEEP,李宁,亿健,舒华,WALKINGPAD,英派斯,SKG,本博,倍轻松,南极人,凯仕乐,佳仁,茗振,小熊,璐瑶,攀高
2020年4月21日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020H1后疫时代全球呼吸机等医疗器械产品监测及企业案例报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对全球范围内的医疗器械产品进行全面分析,并且报告聚焦于疫情问题下的呼吸机、额温枪等医疗器械,具体针对美敦力、GE医疗、迈瑞医疗、万孚生物、鱼跃医疗和乐普医疗等典型案例分析,对2020-2021年医疗器械行业发展进行趋势预判。特别在全球新冠肺炎疫情的严峻情势下,呼吸机、额温枪等医疗器械需求猛增,飞利浦、美敦力等西方医疗器械企业快速提高产量,以支持抗疫工作的迫切需求;同时,中国呼吸机等医疗器械企业的海外业务量有明显增长。艾媒咨询分析师认为,全球疫情势必带动医疗器械行业发展,但中国企业应当在保证自身产品质量的基础上抓住机遇,实现业务出海。
According to the data, the global medical device market has continued to increase in size since 2016, and the global medical device market is expected to reach USD 477.4 billion in 2020. Especially under the influence of the New Crown epidemic, the global demand for medical equipment such as ventilators and oxygen concentrators has increased dramatically. Overseas orders for Chinese medical device companies have skyrocketed. Within a certain period, the concept stocks of ventilator in the A-share market have risen. -
艾媒报告|2019中国综合母婴平台监测报告
本报告研究涉及企业/品牌/案例:宝宝树,亲宝宝,柚宝宝,妈妈网,宝宝知道,妈妈帮,育儿网,辣妈帮,蜜芽
随着二胎政策全面推广以及移动互联网的普及,中国移动母婴行业走上稳健发展的步伐,2019年用户规模将达到2.04亿人。而目前90及95后人群开始走进适育年龄,移动母婴平台的用户开始更替,这部分人群在较为宽松及呵护的环境下成长,对互联网依赖程度高,因此更为青睐使用能提供更多元服务的产品。iiMedia Research(艾媒咨询)数据显示,受访母婴用户用户在平台上最偏好获取育儿知识相关资讯,占比达52.1%。而偏好获取备孕知识、生理健康、孕期护理相关资讯的用户占比也均超过三成,用户资讯获取需求呈现多元化特点。针对用户需求的变化,能综合资讯、知识、交流、电商的综合母婴平台目前成为移动母婴行业的主流。
With the overall promotion of the second child policy and the popularity of the mobile Internet, China Mobile Maternal and Infant Industry has stepped onto a steady pace of development, and the scale of users will reach 204 million in 2019. At present, post-90s and post-95s begin to enter the age of fertility, and the users of mobile maternal and infant platforms begin to change. This group of the population grows up in a more relaxed and caring environment, and is highly dependent on the Internet. Therefore, they prefer to use products that can provide more diversified services. As the data of iiMedia Research showed, interviewed users of mobile maternal and infant platforms preferred to obtain information related to parenting knowledge on the platform, accounting for 52.1%. Meanwhile, more than 30% of the users prefer to acquire information related to pregnant knowledge, physical health and pregnancy care, and their needs for information acquisition are diversified. In response to the changing needs of users, the integrated maternal and infant platforms that integrates information, knowledge, communication and e-commerce services has become the mainstream of the mobile maternal and infant industry. -
艾媒报告 |2019全球及中国大健康产业运行大数据及决策分析报告
本报告研究涉及企业/品牌/案例:恒瑞医药,白云山,111集团,平安好医生,好大夫在线,优健康,春雨医生,微医,丁香医生,和美医疗,北大医疗,PHG,新氧,联合丽格,正广兴家庭医生,强森医疗,微脉,美中嘉和,零氪科技,中有精准医疗,思派网络,普瑞眼科,臻和科技,移宇科技,小鹿医馆,妈咪知道,八百方,京东医药,阿里健康大药房,1药网,一心堂,健一网,好药师,健客网,美丽神器,更美,悦美,美莱整形,伊美尔,丽都整形,芝星整形,欧华美科
大健康产业细分领域的垂直深化,推动了大健康产业格局的不断完善。受政策鼓励和资本推动的影响,2019年,大健康产业在患者服务类领域、医疗服务类领域、医药服务类领域、医疗美容类领域和医疗保健类领域等细分场景快速发展。以恒瑞医药、白云山为代表的传统医药上市公司和以平安好医生、111集团和新氧科技为代表的互联网医疗上市企业各自占据大健康产业领域的一席之地。艾媒商情舆情监测系统数据显示,受2018年和2019年上半年医疗领域负面舆情的影响,大健康产业各上市企业正从低谷平稳回升。艾媒咨询分析师认为,受社会医疗需求和国家政策的推动,大健康产业仍是未来投资的亮点。
The vertical deepening of the large health industry segment has promoted the continuous improvement of the pattern of the big health industry. Influenced by policy encouragement and capital promotion, in 2019, the big health industry developed rapidly in the sub-sectors such as patient service, medical services, medical services, medical and beauty, and health care. The traditional pharmaceutical listed companies represented by Hengrui Medicine and Baiyun Mountain and the Internet medical listed companies represented by Ping An Doctor, 111 Group and New Oxygen Technology each occupy a place in the field of large health industry. According to data from the Aibu Business Intelligence Monitoring System, the listed companies in the big health industry are recovering steadily from the bottom of the market due to the negative public sentiment in the medical field in the first half of 2018 and 2019. Ai Media Consulting analysts believe that the health industry is still the highlight of future investment, driven by social medical needs and national policies. -
艾媒报告 |2019全球及中国口腔护理行业状况与发展趋势大数据分析报告
本报告研究涉及企业/品牌/案例:Straumann,invisalign,隐适美,美亚光电,BEGO,MISI,DENT,JUST,博恩登特,卡瓦集团,NewTom , Dentply Sirona , PLAMENCE , UEG MEDICAL, 泰康拜博口腔,北京大学口腔医院,拜瑞口腔,佳兆业健康集团,国瓷材料,土卓曼集团,牙医管家,茄子,武汉大学口腔医院,通策医疗,可恩口腔,牙博士口腔,阿里健康,一牙网,爱牙,牙医帮
2019年,中国5岁儿童及12岁儿童的龋齿患病率分别为70.9%和34.5%,成年人和老年人群体的牙周问题严重,中国居民口腔健康亟待改善。在国家政策的支持下,2010-2017年间,中国人均卫生费用涨至3738.8元,中国专科医院数量不断上升,口腔医院就诊人数增长到3587.6万人。从中国口腔市场的上下游产业链看,上游端器械市场以Straumann为代表的种植牙企业、典型正畸品牌隐适美以及CBCT巨头亚美广电均实现营收增长,分别于增长了20.7%、37.8%和36.1%;下游端,民营口腔机构达到6.5万个,占据14.2%的市场份额。艾媒咨询分析师认为,民营口腔医疗机构将成为未来中国口腔护理行业投资大市场,并且,“互联网+”和“商业保险+”的模式将逐渐普及。
In 2019, the prevalence of dental caries in Chinese 5-year-old children and 12-year-old children was 70.9% and 34.5%, respectively. Adults had severe periodontal problems, the bleeding rate of gingiva was 87.4%, and the detection rate of calculus was as high as 96.7%. Health needs to be improved. The National Health and Health Committee has established a clear indicator of oral health in 2020-2025. It is expected that the child prevalence rate will be controlled below 30.0%, and the number of remaining teeth in the elderly will reach 24. In 2010-2017, the per capita health expenditure in China rose to 3738.8 yuan. The number of specialized hospitals in China continued to rise. The stomatological hospitals had a large room for development. The number of patients in stomatological hospitals increased to 35.876 million, while the market for Chinese oral stocks was only 103.50 billion yuan. There is an incremental market with great potential. China's oral care upstream device market is expected to reach US$18.30 billion in 2022. The dental implant companies represented by Straumann, the typical orthodontic brand Invisialign and the CBCT giant Meyer all have achieved revenue growth, up 20.7% respectively. 37.8% and 36.1%. At the downstream end, the number of private dental institutions reached 65,000, accounting for 14.2% of the market. It represents the company's Taikang Baibo oral, joint commercial insurance and Internet platform, achieving one-stop service of “insurance + oral care”, as well as online and offline, the omni-channel service model, with revenue growth in 2017, reached 1.43 billion yuan. -
艾媒报告 |2019年中国生物医药产业发展及舆论焦点分析报告
本报告研究涉及企业/品牌包括:Takeda、GSK、Sanofi、Celgene、Novartis、宝洁、CVC Fund VII、Shire、诺华OTC、Bioverativ、Juno Therapeutics、AveXis、Impact Biomedicines、Tesaro、Ablynx、默克OTC、Recordati控股公司FIMEI、复星医药、海正药业、康弘药业、泰合健康、齐鲁制药、复宏汉霖、信达生物、张江生物、恒瑞医药、三生国健、嘉和生物、百奥泰、深圳龙瑞、天坛生物、华兰生物、博雅生物、上海莱士、卫光生物、辽宁成大、智飞生物、康泰生物、沃森生物、利德曼、交大昂立、华润双鹤、力生制药、海欣股份、联环药业、白云山、中源协和、普洛药业
随着生物医药技术不断突破,中国生物医药产业快速发展,2018年,单抗、血液制品、疫苗等生物医药相关领域多家头部上市企业营收均超亿元,实现同比增长。iiMedia Research(艾媒咨询)监测发现,生物医药产业网络言值指数为49.7,网民评价态度偏向正面,上海网民对生物医药产业的关注度最高。未来,随着中国生物医药行业上市公司数量增多,行业与企业间竞争将更加激烈。
The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry. -
艾媒报告 |2019中国3·15消费者权益调查报告网民健康篇
近几年,中国居民人均医疗保健消费支出均保持10%以上的增长水平。2018年居民人均医疗保健消费支出达1685元,同比增长16.1%。中国国内经济增长及居民消费水平的提高刺激了居民医疗消费需求的不断增长。大健康产业蓬勃发展的浪潮中,乱象横生、问题众多。市场监管的不规范、营销骗局层出不穷、假药频出等,不仅骗取群众血汗钱,更是严重危害人民生命健康。艾媒大数据舆情监控系统数据显示,医美、保健品及生物制药成为大健康产业问题重灾区。在健康产业下衍生的各种产品,消费者尤其关注产品的安全性、个人隐私的保护及价格等问题。作为与老百姓生命和健康安全紧密相关的领域,大健康行业在用药安全、销售诚信、售后服务等任何一个环节都容不得半点瑕疵。同时,也对构建更加完善的监管制度、更严格的惩戒体系、更畅通的信息发布机制提出更高的要求。
According to iiMedia Research data, the current demand of logistics enterprises for smart logistics mainly includes logistics data, logistics cloud and logistics equipment. In 2018, the smart logistics market will exceed 400 billion yuan. It is expected that by 2025, the smart logistics market will exceed trillion yuan. iiMedia Consulting analysts believe that with the development of IoT, AI and other technologies, as well as the higher requirements for logistics in new retail, intelligent manufacturing and other fields, the scale of intelligent logistics market will continue to expand. At the same time, the development of new retail, the upgrading of consumer consumption and the increase of user experience expectations have contributed to the gradual expansion of demand in the real-time distribution industry. It is expected that the number of users in China's distribution industry will reach 421 million in 2019, and there is still potential for continued growth.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告